Epilepsia Open · 2020 · 30 citations · 31 references
MedicineNeurologyPharmacotherapyClinical PharmacologyEpilepsyEpileptologyAdult EpilepsyAntiepileptic PharmacotherapyEpilepsy ClassificationSeizure ClassificationSeizure DisordersStatus EpilepticusAnticonvulsant DrugsAntiepileptic Clinical TrialsOverall MortalityStatus Epilepticus In EpilepsyStatus Epilepticus PharmacotherapyStatus Epilepticus TreatmentTreatment Effectiveness AnalysisTreatment Outcomes In Epilepsy
Abstract Objective To evaluate clinical outcomes and treatment effectiveness of status epilepticus finally resolved by nonbenzodiazepine antiepileptic drugs (AEDs). Methods All consecutive SE episodes observed from September 1, 2013, to September 1, 2018, and resolved by AEDs were considered. Diagnosis and classification of SE followed the 2015 ILAE proposal. Nonconvulsive status (NCSE) diagnosis was confirmed according to the Salzburg EEG criteria. The modified Rankin Scale and deaths at 30 days from onset were used to evaluate outcomes. Results A total of 277 status episodes (mean age 71 years; 61% female) were treated and resolved by antiepileptic drugs after 382 treatment trials. 68% of the SE resolved after AED use as first/second treatment line, while subsequent trials with AEDs gave an additional 32% resolution. A return to baseline conditions was observed in 48% of the patients, while overall mortality was 19% without significant changes across the study years. Mortality was higher in NCSE than in convulsive SE (22.5% vs 12.9%; P < .05), while mortality did not differ in SE episodes resolved by a first/second AED trial (17.2%) versus SE resolved by successive treatment trials (18.9%). The resolution rate of intravenous AEDs was 82% for valproate, 77% for lacosamide, 71% for phenytoin, and 62% for levetiracetam. No significant differences were found in head‐to‐head comparison, but for the valproate‐levetiracetam one that was related to NCSE episodes in which valproate resulted to be effective in 86% of the trials while levetiracetam in 62% ( P < .002). Significance A high short‐term mortality, stable over time, was observed in SE despite resolution of seizures, especially in SE with nonconvulsive semiology. Comparative AED efficacy showed no significant differences except for higher resolution rate for valproate versus levetiracetam in NCSE.
31
Guidelines for the Evaluation and Management of Status Epilepticus
Gretchen M. Brophy, Rodney Bell, Jan Claassen et al. · Neurocritical Care · 2012 · 1.6K citations
Medicine, Neurology, Pharmacotherapy +12
A Comparison of Four Treatments for Generalized Convulsive Status Epilepticus
David M. Treiman, Patti D. Meyers, Nancy Y. Walton et al. · New England Journal of Medicine · 1998 · 1.3K citations · Full text
Medicine, Neurology, Pharmacotherapy +17
Tracy A. Glauser, Shlomo Shinnar, David Gloss et al. · Epiliepsy currents/Epilepsy currents · 2016 · 1.2K citations · Full text
Medicine, Neurology, Pediatrics +17
It's Time to Revise the Definition of Status Epilepticus
Daniel H. Lowenstein, Thomas P. Bleck, Robert L. Macdonald · Epilepsia · 1999 · 805 citations · Full text
Medicine, Neurology, Neuroscience +12